跳至主要内容
临床试验/IRCT20121216011763N52
IRCT20121216011763N52已完成3 期

Evaluation of the effect of curcumin-piperine supplementation in patients with coronavirus admitted to the intensive care unit (ICU): a double-blind clinical trial studyCommunity Verified icon

Esfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 80 years(—)
性别
All

入选标准

  • Willingness to participate in the study
  • Age 20-80years
  • Diagnosis of Covid-19 based on clinical findings and PCR findings
  • Gastrointestinal tract with normal function and intestinal nutrition criteria

排除标准

  • Age less than 20 and more than 80 years
  • Sensitivity to plant products such as turmeric and pepper
  • Impossibility of intestinal feeding in the first 48 hours of admission
  • Patients who are hospitalized in the intensive care unit for less than 48 hours.
  • Patients who are expected to die within 12 hours of admission to the intensive care unit.
  • Patients who do not have an indication for intestinal nutrition on the first day and are confirmed and predicted based on the diagnosis of the intensive care unit that they will not be able to receive intestinal nutrition in the future. (Nausea, persistent vomiting, ileus, intestinal obstruction, uncontrolled diarrhea (> 500 ml per day), high-output fistula (> 500 ml per day), intestinal inaccessibility, incomplete resuscitation and hemodynamic instability
  • Patients with BMI <18.5kg / m2 admitted to the intensive care unit.
  • Patients who receive nutritional support through complete intravenous feeding
  • Patients with a history of underlying disease such as congenital and immune disorders, renal and hepatic insufficiency and pancreatitis.Community Verified icon
  • Taking anticoagulants such as heparin, warfarin, aspirin, etc.
  • Pregnancy and lactation
  • Severe septic shock or sepsis
  • Dissatisfaction of the patient or her legal guardian

研究者

相似试验